High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy

Clin Infect Dis. 2015 Jun 15;60(12):1873-5. doi: 10.1093/cid/civ230. Epub 2015 Mar 24.

Affiliations

¹ Department of Biomedical and Clinical Sciences "Luigi Sacco Hospital," University of Milano and Third Division of Infectious Diseases.
² Clinical Microbiology, Virology and Bioemergence Diagnostics.
³ Radiology Unit.
⁴ Second Division of Internal Medicine, Luigi Sacco Hospital, Milan.
⁵ Médecins Sans Frontières, Operational Centre, Rome, Italy.

PMID: 25805302
DOI: 10.1093/cid/civ230

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Chagas Disease / drug therapy*
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Female
Humans
Male
Nitroimidazoles / adverse effects*
Trypanocidal Agents / adverse effects*

Substances

Nitroimidazoles
Trypanocidal Agents